Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL270 Target Snapshot

Mu-type opioid receptor · SINGLE PROTEIN · Rattus norvegicus

3,710Compounds
701Assays
26Approved Drugs
5,011.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P33535. Use UniProt P33535 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P33535 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Mu-type opioid receptor as ChEMBL target CHEMBL270, mapped to UniProt P33535. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Mu-type opioid receptor
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-14
ChEMBL target ID
CHEMBL270
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P33535
Mu-type opioid receptor
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Mu-type opioid receptor is the right protein anchor across sources, using UniProt P33535 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelMu-type opioid receptor
UniProt AccessionP33535
Component TypeProtein
Sequence Length398 aa

Mu-type opioid receptor

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Mu-type opioid receptor, mapped to UniProt P33535. Sequence length is 398 aa.

Mapped IDP33535
Review nameMu-type opioid receptor
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

26
Approved
1
Phase III
12
Phase II
1
Phase I
Assay Mix

Activity Type Distribution

IC50972.0
KI3,477.0
EC50530.0
KD32.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL1649946 11.0 Ki 0.01 Preclinical
CHEMBL254927 11.0 IC50 0.01 Preclinical
CHEMBL3634251 10.92 Ki 0.012 Preclinical
CHEMBL4126050 10.92 EC50 0.012 Preclinical
CHEMBL4126102 10.92 EC50 0.012 Preclinical
CHEMBL4762529 10.9 Ki 0.0125 Preclinical
CHEMBL2369874 10.89 Ki 0.013 Preclinical
CHEMBL2373217 10.89 Ki 0.013 Preclinical
CHEMBL4745764 10.87 Ki 0.0136 Preclinical
CHEMBL365983 10.85 Ki 0.014 Preclinical
Distribution

pChEMBL Value Distribution

247
5.0
394
5.5
423
6.0
500
6.5
575
7.0
495
7.5
508
8.0
461
8.5
407
9.0
294
9.5
pChEMBL
Approved Drugs

Approved Drugs

ELUXADOLINE
CHEMBL2159122
Approved 2015
REMIFENTANIL
CHEMBL1005
Approved 1996
NALMEFENE
CHEMBL982
Approved 1995
ALFENTANIL
CHEMBL634
Approved 1986
NALTREXONE
CHEMBL19019
Approved 1984
SUFENTANIL
CHEMBL658
Approved 1984
MORPHINE
CHEMBL70
Approved 1984
LEVALLORPHAN
CHEMBL1254682
Approved 1982
BUPRENORPHINE
CHEMBL511142
Approved 1981
LOPERAMIDE
CHEMBL841
Approved 1976
NALOXONE
CHEMBL80
Approved 1971
FENTANYL
CHEMBL596
Approved 1968
OXYMORPHONE
CHEMBL963
Approved 1959
OXYCODONE
CHEMBL656
Approved 1950
Assay Landscape

Assay Landscape

701
Total Assays
3,284
Tested Compounds
4
Assay Types
Binding — 558 assays, 3,284 compounds
BAO Format Assays Compounds Avg pChEMBL
cell membrane format 167 1,057 7.5
assay format 121 724 7.5
single protein format 96 371 7.2
cell-based format 88 530 8.1
tissue-based format 77 537 7.4
subcellular format 9 65 7.4
Functional — 141 assays, 373 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 102 289 8.0
cell membrane format 22 47 6.3
assay format 10 33 7.1
tissue-based format 5 1 7.3
single protein format 2 3 6.5
ADME — 1 assays, 4 compounds
BAO Format Assays Compounds Avg pChEMBL
cell membrane format 1 4 6.6
Toxicity — 1 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
cell membrane format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine